On August 21-22, 2025, the 2025 BioSpark Annual Conference will be grandly held at the Sheraton Grand Shanghai Pudong Hotel (hereinafter referred to as the "Annual Conference"). The Annual Conference will simultaneously host two major summits.The 7th Biopharma Developer Innovation Conference (BDIC）AndBIOSeedin 2025 Summer Innovation Collaboration Summit (BIOS）. This year's annual meeting brings together 2000+ industry peers, with dual focuses on "R&D" and "BD Collaboration." BDIC emphasizes R&D and clinical trials, while BIOS concentrates on investment and collaboration deals. Through keynote speeches, panel discussions, innovative company roadshows, and 1-on-1 precise matchmaking, the event establishes deep connections between technological breakthroughs and collaborative transactions.

BDIC LargeWillFocusAntibody drugs and cell therapy, with a focus on early R&D strategies for novel antibodies such as bispecific antibodies and ADCs, antibody optimization, and breakthroughs in solid tumors and in-vivo CAR-T. Four major themes are planned: project initiation and collaboration, differentiated early-stage R&D, clinical translation and international pathways, and the industrialization of cell therapy. An in-depth discussion on innovative experiences in key areas from target identification, antibody discovery, antibody engineering, early CMC development to clinical trial design.

BIOS SummitWill ExtendFollowing the May spring conference, deepen company cooperation and exchange. Create MNC 1-on-1 zones, biotech 1-on-1 partnership zones, and facilitate over 1000 1-on-1 meetings. Concurrently host focused roadshows on autoimmune diseases, oncology, metabolism, and CNS, building bridges for collaboration between MNCs and innovative companies, traditional pharmaceutical enterprises and innovative companies, as well as between China and overseas regions, acting as an accelerator for realizing innovation value in the biopharmaceutical industry.

Looking forward to joining you in this dual symphony of "Technical Depth × Collaboration Density" in the pharmaceutical innovation field on August 21-22, 2025, in Shanghai, to promote the continuous development and progress of the industry.。